QQ客服 官方微博 反馈留言

	Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases
	Ke, Shao-bo; Qiu, Hu; Chen, Jia-mei; Shi, Wei; Chen, Yong-shun
刊名	CURRENT MEDICAL SCIENCE
	2018
卷号	38期号:6
关键词	lung adenocarcinoma brain metastases epidermal growth factor receptor tyrosine kinase inhibitor whole brain radiotherapy
ISSN号	2096-5230
DOI	10.1007/s11596-018-1984-0
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4143467
专题	武汉大学
推荐引用方式 GB/T 7714	Ke, Shao-bo,Qiu, Hu,Chen, Jia-mei,et al. Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases[J]. CURRENT MEDICAL SCIENCE,2018,38(6).
APA	Ke, Shao-bo,Qiu, Hu,Chen, Jia-mei,Shi, Wei,&Chen, Yong-shun.(2018).Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases.CURRENT MEDICAL SCIENCE,38(6).
MLA	Ke, Shao-bo,et al."Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases".CURRENT MEDICAL SCIENCE 38.6(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。